Details for New Drug Application (NDA): 020246
✉ Email this page to a colleague
NDA 020246 describes DEPO-PROVERA, which is a drug marketed by Pfizer and is included in two NDAs. It is available from three suppliers. Additional details are available on the DEPO-PROVERA profile page.
The generic ingredient in DEPO-PROVERA is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
The generic ingredient in DEPO-PROVERA is medroxyprogesterone acetate. There are twenty drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
Summary for 020246
| Tradename: | DEPO-PROVERA |
| Applicant: | Pfizer |
| Ingredient: | medroxyprogesterone acetate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 020246
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DEPO-PROVERA | medroxyprogesterone acetate | INJECTABLE;INJECTION | 020246 | NDA | Pharmacia & Upjohn Company LLC | 0009-0746 | 0009-0746-30 | 1 VIAL in 1 CARTON (0009-0746-30) / 1 mL in 1 VIAL |
| DEPO-PROVERA | medroxyprogesterone acetate | INJECTABLE;INJECTION | 020246 | NDA | Pharmacia & Upjohn Company LLC | 0009-0746 | 0009-0746-35 | 25 VIAL in 1 PACKAGE (0009-0746-35) / 1 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 150MG/ML | ||||
| Approval Date: | Oct 29, 1992 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
